
\section*{Esophagus Muscularis}
\begin{figure}[h!]
\centering
\includegraphics[width=.9\textwidth]{figures/tissue_prediction_from_Esophagus_Muscularis.pdf}
\end{figure}



\subsection*{Community with ID 1}
This community has the following genes: CTRC, CELA2A, CELA2B, CELA3B, CELA3A, AMY2A, REG1B, REG1A, REG3A, CPB1, SPINK1, CLPS, CPA2, CPA1, PRSS1, CEL, PNLIP, PNLIPRP1, INS, PLA2G1B, GP2, CTRB2, CTRB1, SYCN, RBPJL, REG3G
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 1}\\
\toprule
Adjusted \newline P-value &                                                                             Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
                 0.000008 &                             Digestion of dietary lipid Homo sapiens R-HSA-192456 \\
                 0.000010 &  Cobalamin (Cbl, vitamin B12) transport and metabolism Homo sapiens R-HSA-196741 \\
                 0.000015 &                   Metabolism of vitamins and cofactors Homo sapiens R-HSA-196854 \\
                 0.000786 &            Lipid digestion, mobilization, and transport Homo sapiens R-HSA-73923 \\
                 0.002282 &     Metabolism of water-soluble vitamins and cofactors Homo sapiens R-HSA-196849 \\
                 0.002406 &               Activation of Matrix Metalloproteinases Homo sapiens R-HSA-1592389 \\
                 0.002519 &                                            Metabolism Homo sapiens R-HSA-1430728 \\
\end{longtable}


\begin{longtable}{lrrrrrrrrrrrrrrrrrrrrrrrrr}
\caption{Connectivity of community 1}\\
\toprule
{} & \rot{CELA2A} & \rot{CELA2B} & \rot{CELA3B} & \rot{CELA3A} & \rot{AMY2A} & \rot{REG1B} & \rot{REG1A} & \rot{REG3A} & \rot{CPB1} & \rot{SPINK1} & \rot{CLPS} & \rot{CPA2} & \rot{CPA1} & \rot{PRSS1} & \rot{CEL} & \rot{PNLIP} & \rot{PNLIPRP1} & \rot{INS} & \rot{PLA2G1B} & \rot{GP2} & \rot{CTRB2} & \rot{CTRB1} & \rot{SYCN} & \rot{RBPJL} & \rot{REG3G} \\
\midrule
\endhead
\midrule
\multicolumn{26}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
CTRC     &         1.13 &         0.79 &         1.18 &         1.20 &        0.94 &        0.75 &        0.92 &        0.52 &       1.15 &         0.86 &       1.22 &       1.16 &       1.13 &        1.21 &      1.08 &        1.16 &           1.14 &      0.86 &          1.12 &      1.13 &        1.14 &        1.23 &       1.10 &        0.79 &        0.51 \\
CELA2A   &              &         0.89 &         1.32 &         1.33 &        1.04 &        0.75 &        0.93 &        0.46 &       1.23 &         0.87 &       1.36 &       1.15 &       1.40 &        1.44 &      1.13 &        1.48 &           1.15 &      0.83 &          1.26 &      1.18 &        1.20 &        1.26 &       1.20 &        0.78 &        0.43 \\
CELA2B   &              &              &         0.85 &         0.86 &        0.79 &        0.50 &        0.60 &        0.30 &       0.84 &         0.61 &       0.86 &       0.82 &       0.84 &        0.88 &      0.84 &        0.95 &           0.81 &      0.58 &          0.83 &      0.80 &        0.80 &        0.85 &       0.86 &        0.60 &        0.28 \\
CELA3B   &              &              &              &         1.65 &        0.99 &        0.95 &        1.14 &        0.52 &       1.34 &         1.02 &       1.48 &       1.43 &       1.62 &        1.57 &      1.22 &        1.44 &           1.39 &      0.96 &          1.40 &      1.50 &        1.57 &        1.48 &       1.35 &        0.89 &        0.54 \\
CELA3A   &              &              &              &              &        1.00 &        0.94 &        1.20 &        0.55 &       1.30 &         1.07 &       1.57 &       1.43 &       1.63 &        1.64 &      1.20 &        1.52 &           1.46 &      0.96 &          1.46 &      1.61 &        1.54 &        1.55 &       1.35 &        0.91 &        0.56 \\
AMY2A    &              &              &              &              &             &        0.63 &        0.74 &        0.38 &       0.98 &         0.74 &       1.01 &       0.98 &       1.01 &        1.06 &      0.95 &        1.11 &           0.94 &      0.68 &          1.01 &      0.97 &        0.93 &        0.96 &       0.93 &        0.66 &        0.42 \\
REG1B    &              &              &              &              &             &             &        1.37 &        0.85 &       0.86 &         0.98 &       0.88 &       0.92 &       0.91 &        0.87 &      0.83 &        0.78 &           0.97 &      0.72 &          0.91 &      1.09 &        0.97 &        0.93 &       0.72 &        0.62 &        0.81 \\
REG1A    &              &              &              &              &             &             &             &        0.80 &       1.00 &         1.16 &       1.12 &       1.15 &       1.16 &        1.12 &      0.96 &        1.03 &           1.14 &      0.80 &          1.09 &      1.34 &        1.17 &        1.12 &       0.90 &        0.77 &        0.73 \\
REG3A    &              &              &              &              &             &             &             &             &       0.55 &         0.65 &       0.56 &       0.56 &       0.54 &        0.56 &      0.53 &        0.48 &           0.57 &      0.46 &          0.55 &      0.60 &        0.58 &        0.56 &       0.44 &        0.43 &        0.72 \\
CPB1     &              &              &              &              &             &             &             &             &            &         0.97 &       1.27 &       1.30 &       1.39 &        1.35 &      1.19 &        1.33 &           1.21 &      0.87 &          1.29 &      1.25 &        1.29 &        1.26 &       1.15 &        0.85 &        0.53 \\
SPINK1   &              &              &              &              &             &             &             &             &            &              &       1.02 &       1.08 &       1.04 &        0.99 &      0.94 &        0.92 &           1.04 &      0.77 &          1.02 &      1.11 &        1.03 &        1.02 &       0.87 &        0.77 &        0.64 \\
CLPS     &              &              &              &              &             &             &             &             &            &              &            &       1.31 &       1.53 &        1.64 &      1.13 &        1.60 &           1.29 &      0.91 &          1.39 &      1.44 &        1.40 &        1.47 &       1.31 &        0.85 &        0.55 \\
CPA2     &              &              &              &              &             &             &             &             &            &              &            &            &       1.43 &        1.43 &      1.17 &        1.31 &           1.38 &      0.88 &          1.33 &      1.43 &        1.45 &        1.34 &       1.19 &        0.90 &        0.61 \\
CPA1     &              &              &              &              &             &             &             &             &            &              &            &            &            &        1.77 &      1.20 &        1.53 &           1.34 &      0.93 &          1.37 &      1.55 &        1.57 &        1.48 &       1.32 &        0.88 &        0.54 \\
PRSS1    &              &              &              &              &             &             &             &             &            &              &            &            &            &             &      1.18 &        1.74 &           1.31 &      0.90 &          1.38 &      1.52 &        1.47 &        1.47 &       1.34 &        0.86 &        0.52 \\
CEL      &              &              &              &              &             &             &             &             &            &              &            &            &            &             &           &        1.13 &           1.17 &      0.82 &          1.20 &      1.19 &        1.20 &        1.22 &       1.05 &        0.85 &        0.53 \\
PNLIP    &              &              &              &              &             &             &             &             &            &              &            &            &            &             &           &             &           1.25 &      0.85 &          1.34 &      1.35 &        1.34 &        1.35 &       1.34 &        0.85 &        0.47 \\
PNLIPRP1 &              &              &              &              &             &             &             &             &            &              &            &            &            &             &           &             &                &      0.94 &          1.35 &      1.48 &        1.38 &        1.37 &       1.17 &        0.93 &        0.59 \\
INS      &              &              &              &              &             &             &             &             &            &              &            &            &            &             &           &             &                &           &          0.88 &      0.96 &        0.98 &        0.96 &       0.88 &        0.72 &        0.49 \\
PLA2G1B  &              &              &              &              &             &             &             &             &            &              &            &            &            &             &           &             &                &           &               &      1.34 &        1.33 &        1.35 &       1.21 &        0.86 &        0.56 \\
GP2      &              &              &              &              &             &             &             &             &            &              &            &            &            &             &           &             &                &           &               &           &        1.49 &        1.44 &       1.19 &        0.89 &        0.62 \\
CTRB2    &              &              &              &              &             &             &             &             &            &              &            &            &            &             &           &             &                &           &               &           &             &        1.50 &       1.26 &        0.87 &        0.55 \\
CTRB1    &              &              &              &              &             &             &             &             &            &              &            &            &            &             &           &             &                &           &               &           &             &             &       1.27 &        0.90 &        0.53 \\
SYCN     &              &              &              &              &             &             &             &             &            &              &            &            &            &             &           &             &                &           &               &           &             &             &            &        0.91 &        0.45 \\
RBPJL    &              &              &              &              &             &             &             &             &            &              &            &            &            &             &           &             &                &           &               &           &             &             &            &             &        0.45 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkEsophagus_Muscularis_1.pdf}
\caption{Community 1 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 2}
This community has the following genes: C1QA, C1QC, C1QB, FOLR2
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 2}\\
\toprule
Adjusted \newline P-value &                                                                         Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
                 0.000057 &  Classical antibody-mediated complement activation Homo sapiens R-HSA-173623 \\
                 0.000042 &                   Creation of C4 and C2 activators Homo sapiens R-HSA-166786 \\
                 0.000047 &                   Initial triggering of complement Homo sapiens R-HSA-166663 \\
                 0.000094 &                                 Complement cascade Homo sapiens R-HSA-166658 \\
\end{longtable}


\begin{longtable}{lrrr}
\caption{Connectivity of community 2}\\
\toprule
{} & \rot{C1QC} & \rot{C1QB} & \rot{FOLR2} \\
\midrule
\endhead
\midrule
\multicolumn{4}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
C1QA &       1.36 &       1.50 &        0.93 \\
C1QC &            &       1.56 &        0.77 \\
C1QB &            &            &        0.74 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkEsophagus_Muscularis_2.pdf}
\caption{Community 2 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 3}
This community has the following genes: FLG2, C1orf68, LOR, CALML5, KRT2, KRT1, DCD, SERPINA12, KRT10, DSG1, CASP14, KRTDAP
\\
This community has no enriched pathways below adjusted p-value $< 0.05$.

\begin{longtable}{lrrrrrrrrrrr}
\caption{Connectivity of community 3}\\
\toprule
{} & \rot{C1orf68} & \rot{LOR} & \rot{CALML5} & \rot{KRT2} & \rot{KRT1} & \rot{DCD} & \rot{SERPINA12} & \rot{KRT10} & \rot{DSG1} & \rot{CASP14} & \rot{KRTDAP} \\
\midrule
\endhead
\midrule
\multicolumn{12}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
FLG2      &          0.81 &      0.98 &         0.93 &       0.94 &       0.91 &      0.79 &            0.85 &        0.70 &       0.79 &         0.90 &         0.81 \\
C1orf68   &               &      0.86 &         0.76 &       0.74 &       0.69 &      0.70 &            0.65 &        0.62 &       0.61 &         0.69 &         0.69 \\
LOR       &               &           &         1.02 &       0.98 &       0.92 &      0.83 &            0.81 &        0.67 &       0.76 &         0.89 &         0.90 \\
CALML5    &               &           &              &       0.96 &       0.88 &      0.73 &            0.74 &        0.72 &       0.75 &         0.88 &         0.91 \\
KRT2      &               &           &              &            &       1.00 &      0.78 &            0.82 &        0.84 &       0.88 &         0.89 &         0.73 \\
KRT1      &               &           &              &            &            &      0.68 &            0.78 &        0.80 &       0.86 &         0.91 &         0.87 \\
DCD       &               &           &              &            &            &           &            0.64 &        0.55 &       0.67 &         0.75 &         0.75 \\
SERPINA12 &               &           &              &            &            &           &                 &        0.66 &       0.75 &         0.73 &         0.68 \\
KRT10     &               &           &              &            &            &           &                 &             &       0.68 &         0.71 &         0.64 \\
DSG1      &               &           &              &            &            &           &                 &             &            &         0.80 &         0.69 \\
CASP14    &               &           &              &            &            &           &                 &             &            &              &         0.83 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkEsophagus_Muscularis_3.pdf}
\caption{Community 3 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 4}
This community has the following genes: NPAS2, CCZ1B, ARNTL, MTERFD3, RP11.82O18.1, GSTT2B
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 4}\\
\toprule
Adjusted \newline P-value &                                                                              Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
                 0.003210 &             NR1D1 (REV-ERBA) represses gene expression Homo sapiens R-HSA-1368071 \\
                 0.020072 &                         RORA activates gene expression Homo sapiens R-HSA-1368082 \\
                 0.032758 &  BMAL1:CLOCK,NPAS2 activates circadian gene expression Homo sapiens R-HSA-1368108 \\
\end{longtable}


\begin{longtable}{lrrrrr}
\caption{Connectivity of community 4}\\
\toprule
{} & \rot{CCZ1B} & \rot{ARNTL} & \rot{MTERFD3} & \rot{RP11.82O18.1} & \rot{GSTT2B} \\
\midrule
\endhead
\midrule
\multicolumn{6}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
NPAS2        &        0.05 &        0.96 &          0.67 &               0.06 &         0.05 \\
CCZ1B        &             &        0.04 &          0.03 &              -0.04 &        -0.00 \\
ARNTL        &             &             &          0.87 &               0.01 &         0.06 \\
MTERFD3      &             &             &               &              -0.07 &         0.03 \\
RP11.82O18.1 &             &             &               &                    &         0.06 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkEsophagus_Muscularis_4.pdf}
\caption{Community 4 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 5}
This community has the following genes: CRP, APOA2, ALB, FGB, FGA, FGG, AMBP, ORM1, ORM2, APOC3, HP, APOH
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 5}\\
\toprule
Adjusted \newline P-value &                                                                                          Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
             1.063545e-10 &                                              Platelet degranulation Homo sapiens R-HSA-114608 \\
             7.426625e-11 &                         Response to elevated platelet cytosolic Ca2+ Homo sapiens R-HSA-76005 \\
             1.825596e-08 &                       Platelet activation, signaling and aggregation Homo sapiens R-HSA-76002 \\
             3.155958e-06 &                                                          Hemostasis Homo sapiens R-HSA-109582 \\
             2.288055e-05 &           GRB2:SOS provides linkage to MAPK signaling for Integrins Homo sapiens R-HSA-354194 \\
             1.906712e-05 &                     p130Cas linkage to MAPK signaling for integrins Homo sapiens R-HSA-372708 \\
             5.518602e-05 &                             Common Pathway of Fibrin Clot Formation Homo sapiens R-HSA-140875 \\
             9.156148e-05 &                                   Integrin alphaIIb beta3 signaling Homo sapiens R-HSA-354192 \\
             1.661129e-04 &                                              Lipoprotein metabolism Homo sapiens R-HSA-174824 \\
             1.939263e-04 &                                Platelet Aggregation (Plug Formation) Homo sapiens R-HSA-76009 \\
             1.913433e-04 &                                          MAP2K and MAPK activation Homo sapiens R-HSA-5674135 \\
             1.899505e-04 &                         Formation of Fibrin Clot (Clotting Cascade) Homo sapiens R-HSA-140877 \\
             2.905542e-04 &                                     Scavenging of heme from plasma Homo sapiens R-HSA-2168880 \\
             8.454258e-04 &                                  Integrin cell surface interactions Homo sapiens R-HSA-216083 \\
             9.401547e-04 &                         Lipid digestion, mobilization, and transport Homo sapiens R-HSA-73923 \\
             9.986479e-04 &               Binding and Uptake of Ligands by Scavenger Receptors Homo sapiens R-HSA-2173782 \\
             4.019057e-03 &                                Chylomicron-mediated lipid transport Homo sapiens R-HSA-174800 \\
             4.769460e-03 &                                        HDL-mediated lipid transport Homo sapiens R-HSA-194223 \\
             2.257725e-02 &                                   Retinoid metabolism and transport Homo sapiens R-HSA-975634 \\
             2.492305e-02 &                                       GRB2 events in EGFR signaling Homo sapiens R-HSA-179812 \\
             2.373623e-02 &                                       SHC1 events in EGFR signaling Homo sapiens R-HSA-180336 \\
             2.265731e-02 &                                             SOS-mediated signalling Homo sapiens R-HSA-112412 \\
             2.167221e-02 &                                     SHC1 events in ERBB4 signaling Homo sapiens R-HSA-1250347 \\
             2.076920e-02 &                                             RAF/MAP kinase cascade Homo sapiens R-HSA-5673001 \\
             2.018831e-02 &                                       FRS-mediated FGFR2 signaling Homo sapiens R-HSA-5654700 \\
             1.941184e-02 &                                       FRS-mediated FGFR4 signaling Homo sapiens R-HSA-5654712 \\
             1.869288e-02 &                                       FRS-mediated FGFR3 signaling Homo sapiens R-HSA-5654706 \\
             1.802528e-02 &                                       FRS-mediated FGFR1 signaling Homo sapiens R-HSA-5654693 \\
             1.806043e-02 &                                            ARMS-mediated activation Homo sapiens R-HSA-170984 \\
             1.745841e-02 &                                   Signalling to p38 via RIT and RIN Homo sapiens R-HSA-187706 \\
             1.710330e-02 &                                            Frs2-mediated activation Homo sapiens R-HSA-170968 \\
             1.677199e-02 &                                              MAPK1/MAPK3 signaling Homo sapiens R-HSA-5684996 \\
             1.646232e-02 &                                     Prolonged ERK activation events Homo sapiens R-HSA-169893 \\
             1.617238e-02 &                                                Signaling by Leptin Homo sapiens R-HSA-2586552 \\
             1.609214e-02 &                                  Interleukin receptor SHC signaling Homo sapiens R-HSA-912526 \\
             1.583292e-02 &                                                   Signalling to RAS Homo sapiens R-HSA-167044 \\
             1.577466e-02 &                                 VEGFR2 mediated cell proliferation Homo sapiens R-HSA-5218921 \\
             1.609608e-02 &                                             Interleukin-2 signaling Homo sapiens R-HSA-451927 \\
             1.586618e-02 &                                                  Signalling to ERKs Homo sapiens R-HSA-187687 \\
             1.583324e-02 &                                 Metabolism of fat-soluble vitamins Homo sapiens R-HSA-6806667 \\
             1.653081e-02 &                               Interleukin-3, 5 and GM-CSF signaling Homo sapiens R-HSA-512988 \\
             1.705730e-02 &                               NCAM signaling for neurite out-growth Homo sapiens R-HSA-375165 \\
             1.996172e-02 &                                  Extracellular matrix organization Homo sapiens R-HSA-1474244 \\
             1.970963e-02 &                                             IRS-mediated signalling Homo sapiens R-HSA-112399 \\
             1.927164e-02 &                                     MAPK family signaling cascades Homo sapiens R-HSA-5683057 \\
             1.943884e-02 &                                  Insulin receptor signalling cascade Homo sapiens R-HSA-74751 \\
             1.921899e-02 &                                            IGF1R signaling cascade Homo sapiens R-HSA-2428924 \\
             1.881860e-02 &  Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) Homo sapiens R-HSA-2404192 \\
             1.843455e-02 &                              IRS-related events triggered by IGF1R Homo sapiens R-HSA-2428928 \\
             1.824917e-02 &                                     FCERI mediated MAPK activation Homo sapiens R-HSA-2871796 \\
             2.214674e-02 &                                        Signaling by Insulin receptor Homo sapiens R-HSA-74752 \\
             2.359595e-02 &                                               VEGFA-VEGFR2 Pathway Homo sapiens R-HSA-4420097 \\
             2.421537e-02 &                                               Signaling by SCF-KIT Homo sapiens R-HSA-1433557 \\
             2.440840e-02 &                                                   Signaling by VEGF Homo sapiens R-HSA-194138 \\
             2.417694e-02 &                            Downstream signaling of activated FGFR2 Homo sapiens R-HSA-5654696 \\
             2.374521e-02 &                            Downstream signaling of activated FGFR4 Homo sapiens R-HSA-5654716 \\
             2.332863e-02 &                            Downstream signaling of activated FGFR3 Homo sapiens R-HSA-5654708 \\
             2.312889e-02 &                                                 Signaling by ERBB4 Homo sapiens R-HSA-1236394 \\
             2.313834e-02 &                                                 Signaling by FGFR4 Homo sapiens R-HSA-5654743 \\
             2.275271e-02 &                            Downstream signaling of activated FGFR1 Homo sapiens R-HSA-5654687 \\
             2.257550e-02 &                                                 Signaling by FGFR3 Homo sapiens R-HSA-5654741 \\
             2.279573e-02 &                                                 Signaling by FGFR1 Homo sapiens R-HSA-5654736 \\
             2.341369e-02 &                                      Downstream signal transduction Homo sapiens R-HSA-186763 \\
             2.363926e-02 &                                                    DAP12 signaling Homo sapiens R-HSA-2424491 \\
             2.364515e-02 &                                                Innate Immune System Homo sapiens R-HSA-168249 \\
             2.510588e-02 &                                                   Signaling by EGFR Homo sapiens R-HSA-177929 \\
             2.554430e-02 &                                                 DAP12 interactions Homo sapiens R-HSA-2172127 \\
             2.557546e-02 &                                                 Signaling by FGFR2 Homo sapiens R-HSA-5654738 \\
             2.581387e-02 &                                                   Signaling by PDGF Homo sapiens R-HSA-186797 \\
             2.585044e-02 &                                                   Signaling by FGFR Homo sapiens R-HSA-190236 \\
             2.712537e-02 &                    NGF signalling via TRKA from the plasma membrane Homo sapiens R-HSA-187037 \\
             3.062314e-02 &                                           Signaling by Interleukins Homo sapiens R-HSA-449147 \\
             3.087274e-02 &                              Fc epsilon receptor (FCERI) signaling Homo sapiens R-HSA-2454202 \\
             3.077838e-02 &                                           Visual phototransduction Homo sapiens R-HSA-2187338 \\
             3.884351e-02 &                    Gastrin-CREB signalling pathway via PKC and MAPK Homo sapiens R-HSA-881907 \\
             4.307400e-02 &                                                   Signalling by NGF Homo sapiens R-HSA-166520 \\
\end{longtable}


\begin{longtable}{lrrrrrrrrrrr}
\caption{Connectivity of community 5}\\
\toprule
{} & \rot{APOA2} & \rot{ALB} & \rot{FGB} & \rot{FGA} & \rot{FGG} & \rot{AMBP} & \rot{ORM1} & \rot{ORM2} & \rot{APOC3} & \rot{HP} & \rot{APOH} \\
\midrule
\endhead
\midrule
\multicolumn{12}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
CRP   &        0.48 &      0.52 &      0.97 &      0.98 &      0.96 &       0.54 &       0.86 &       0.65 &        0.38 &     0.63 &       0.54 \\
APOA2 &             &      0.86 &      0.77 &      0.75 &      0.70 &       0.74 &       0.71 &       0.61 &        0.80 &     0.55 &       0.69 \\
ALB   &             &           &      0.85 &      0.86 &      0.79 &       0.88 &       0.79 &       0.67 &        0.87 &     0.55 &       0.79 \\
FGB   &             &           &           &      1.48 &      1.29 &       0.86 &       1.19 &       0.81 &        0.63 &     0.79 &       0.81 \\
FGA   &             &           &           &           &      1.34 &       0.87 &       1.19 &       0.86 &        0.63 &     0.75 &       0.80 \\
FGG   &             &           &           &           &           &       0.79 &       1.16 &       0.81 &        0.56 &     0.77 &       0.77 \\
AMBP  &             &           &           &           &           &            &       0.86 &       0.70 &        0.72 &     0.62 &       0.72 \\
ORM1  &             &           &           &           &           &            &            &       0.93 &        0.65 &     0.82 &       0.76 \\
ORM2  &             &           &           &           &           &            &            &            &        0.59 &     0.68 &       0.64 \\
APOC3 &             &           &           &           &           &            &            &            &             &     0.50 &       0.63 \\
HP    &             &           &           &           &           &            &            &            &             &          &       0.60 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkEsophagus_Muscularis_5.pdf}
\caption{Community 5 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 7}
This community has the following genes: CD74, HLA.DRA, HLA.DRB1, HLA.DOA, HLA.DPA1, HLA.DPB1
\\
This community has no enriched pathways below adjusted p-value $< 0.05$.

\begin{longtable}{lrrrrr}
\caption{Connectivity of community 7}\\
\toprule
{} & \rot{HLA.DRA} & \rot{HLA.DRB1} & \rot{HLA.DOA} & \rot{HLA.DPA1} & \rot{HLA.DPB1} \\
\midrule
\endhead
\midrule
\multicolumn{6}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
CD74     &          1.11 &           0.85 &          0.81 &           1.02 &           0.97 \\
HLA.DRA  &               &           0.91 &          0.76 &           0.97 &           1.01 \\
HLA.DRB1 &               &                &          0.54 &           0.83 &           0.73 \\
HLA.DOA  &               &                &               &           0.69 &           0.73 \\
HLA.DPA1 &               &                &               &                &           0.94 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkEsophagus_Muscularis_7.pdf}
\caption{Community 7 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 9}
This community has the following genes: MMRN1, PKHD1L1, SCN3B, TBX1
\\
This community has no enriched pathways below adjusted p-value $< 0.05$.

\begin{longtable}{lrrr}
\caption{Connectivity of community 9}\\
\toprule
{} & \rot{PKHD1L1} & \rot{SCN3B} & \rot{TBX1} \\
\midrule
\endhead
\midrule
\multicolumn{4}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
MMRN1   &          0.83 &        0.63 &       0.76 \\
PKHD1L1 &               &        0.68 &       0.84 \\
SCN3B   &               &             &       0.80 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkEsophagus_Muscularis_9.pdf}
\caption{Community 9 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 11}
This community has the following genes: SFTPB, SLC34A2, SFTPC, SFTPA2, SFTPA1
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 11}\\
\toprule
Adjusted \newline P-value &                                                                                                          Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
             5.735973e-12 &  Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3) Homo sapiens R-HSA-5683678 \\
             3.406714e-12 &                                                              Surfactant metabolism Homo sapiens R-HSA-5683826 \\
             2.676681e-11 &      Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5) Homo sapiens R-HSA-5688849 \\
             2.007511e-11 &      Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4) Homo sapiens R-HSA-5688890 \\
             1.606009e-11 &                                                          ABC transporter disorders Homo sapiens R-HSA-5619084 \\
             4.014827e-11 &                                     Diseases associated with surfactant metabolism Homo sapiens R-HSA-5687613 \\
             2.236498e-10 &                                            Disorders of transmembrane transporters Homo sapiens R-HSA-5619115 \\
             2.133747e-08 &                                                             Diseases of metabolism Homo sapiens R-HSA-5668914 \\
             7.523914e-05 &                                                              Metabolism of proteins Homo sapiens R-HSA-392499 \\
             1.272575e-03 &                                                                            Disease Homo sapiens R-HSA-1643685 \\
\end{longtable}


\begin{longtable}{lrrrr}
\caption{Connectivity of community 11}\\
\toprule
{} & \rot{SLC34A2} & \rot{SFTPC} & \rot{SFTPA2} & \rot{SFTPA1} \\
\midrule
\endhead
\midrule
\multicolumn{5}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
SFTPB   &          0.82 &        0.95 &         1.21 &         1.22 \\
SLC34A2 &               &        0.63 &         0.77 &         0.75 \\
SFTPC   &               &             &         0.98 &         1.05 \\
SFTPA2  &               &             &              &         1.32 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkEsophagus_Muscularis_11.pdf}
\caption{Community 11 structure. Only showing connections with correlation greater than 0.8}
\end{figure}




\subsection*{Community with ID 13}
This community has the following genes: HBB, HBD, HBA2, HBA1, ALAS2
\\
\begin{longtable}{p{2.4cm}p{14.5cm}}
\caption{Enrichment for community 13}\\
\toprule
Adjusted \newline P-value &                                                                               Term \\
\midrule
\endhead
\midrule
\multicolumn{2}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
                 0.002141 &  Erythrocytes take up oxygen and release carbon dioxide Homo sapiens R-HSA-1247673 \\
                 0.002522 &  Erythrocytes take up carbon dioxide and release oxygen Homo sapiens R-HSA-1237044 \\
                 0.001681 &                         O2/CO2 exchange in erythrocytes Homo sapiens R-HSA-1480926 \\
                 0.019707 &                          Scavenging of heme from plasma Homo sapiens R-HSA-2168880 \\
                 0.041029 &    Binding and Uptake of Ligands by Scavenger Receptors Homo sapiens R-HSA-2173782 \\
\end{longtable}


\begin{longtable}{lrrrr}
\caption{Connectivity of community 13}\\
\toprule
{} & \rot{HBD} & \rot{HBA2} & \rot{HBA1} & \rot{ALAS2} \\
\midrule
\endhead
\midrule
\multicolumn{5}{r}{{Continued on next page}} \\
\midrule
\endfoot

\bottomrule
\endlastfoot
HBB  &      0.85 &       1.94 &       1.30 &        0.87 \\
HBD  &           &       0.84 &       0.87 &        0.77 \\
HBA2 &           &            &       1.31 &        0.81 \\
HBA1 &           &            &            &        0.80 \\
\end{longtable}


\begin{figure}[h!]
\centering
\includegraphics[width=.5\textwidth]{corr_figures/corr_networkEsophagus_Muscularis_13.pdf}
\caption{Community 13 structure. Only showing connections with correlation greater than 0.8}
\end{figure}


